Answers are grounded in this paper and cite their sources.
Abstract ID 129282 Poster Board 041 Introduction: Benzalkonium chlorides (BACs) are quaternary ammonium antimicrobials used in disinfectants, consumer products, pharmaceutical formulation, and food processing. Due to this high frequency of exposure, BACs are pseudo-persistent environmental molecules that have been detected in 80% to 98% of human blood samples. To understand how humans metabolize and clear BACs from the body, our study investigated the cytochrome P450 enzyme kinetics of BAC metabolism in human liver microsomes (HLM). Method: BACs (0.125 – 128 μM) of varying alkyl side chain length (C10, C12, C14, and C16) were incubated in NADPH-supplemented HLM (0.1 - 0.2 mg/mL). Incubations were kept brief (0.5 – 7.5 min) to capture the initial rates of linear product formation. After terminating the reactions with ice-cold ACN (+internal standards), levels of ω and ω-1 oxidized BAC metabolites (hydroxy, ketone, and COOH) were measured by LC-MS/MS. Fitting of the kinetic model and the estimation of Km and Vmax values were determined by nonlinear regression in GraphPad Prism. In addition, Eadie-Hofstee plots were used to discern single enzyme vs multiple enzyme kinetics. Results and Conclusion: The kinetic profiles of C12-, C14-, and C16-BAC ω- and (ω−1)-hydroxylation all exhibited a better fit for the substrate inhibition model, while C10-BAC ω- and (ω−1)-hydroxylation both fit the standard Michaelis-Menten model. Apparent Km values increased with BAC alkyl length, suggesting that shorter chain BACs are higher affinity substrates. Another interpretation, however, is that non-specific binding of longer chain BACs lowers their unbound concentrations and raises their apparent Km values. For C10-, C12-, C14-, and C16-BAC, respectively, the Vmax values for ω-hydroxylation were 3-, 3-, 13-, and 23-fold higher than the Vmax of (ω-1)-hydroxylation; thus, ω-oxidation was preferred for all chain lengths, and became increasingly dominant at longer alkyl length. Linearity in the Eadie-Hofstee plot for ω-hydroxylation of C10-BAC provided evidence for a single enzyme contribution in this reaction. All other Eadie-Hofstee plots were nonlinear (biphasic), indicating the participation of two or more microsomal P450 enzymes in most cases. While obtaining kinetic parameters at an individual enzyme level is an ongoing effort in the lab, fitting the data to single enzyme kinetics was employed to estimate microsomal intrinsic clearance values. Intrinsic clearance estimates for ω-hydroxylation were between 2- to 5-fold higher than for (ω-1)-hydroxylation. Lastly, metabolic clearance in HLM is estimated to be more rapid for the shorter chain BACs while longer chain BACs are cleared more slowly. Future Directions: Further investigation is needed to determine whether the apparent substrate inhibition is true substrate inhibition or whether it may be an in vitro artifact wherein the surfactant property of BAC potentially destabilizes the microsomal membrane structure, P450 enzymes, and/or P450 reductase. Additionally, measurement of unbound BAC concentrations in HLM incubations will be conducted to convert apparent Km values to their unbound counterparts. Finally, kinetic characterization of BAC metabolism by recombinant P450 enzymes will better inform the multiple enzyme kinetics observed in HLM. Funding support: NIEHS R01ES031927
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: